Chronic Myeloid Leukæmia with a Goitre and Raised B.M.R.
作者信息
Richardson J S
出版信息
Proc R Soc Med. 1946 Apr;39(6):311-3. doi: 10.1177/003591574603900615.
Abstract
摘要
相似文献
1
Chronic Myeloid Leukæmia with a Goitre and Raised B.M.R.
Proc R Soc Med. 1946 Apr;39(6):311-3. doi: 10.1177/003591574603900615.
2
Plasma levels of highly sulphated glycosaminoglycans are raised in patients with chronic myeloid leukaemia.
Br J Haematol. 1988 Sep;70(1):27-9. doi: 10.1111/j.1365-2141.1988.tb02429.x.
3
Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML).
J Transl Med. 2022 Dec 14;20(1):600. doi: 10.1186/s12967-022-03797-7.
4
A case-control study to investigate the risk of leukaemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom.
Occup Environ Med. 1997 Mar;54(3):152-66. doi: 10.1136/oem.54.3.152.
5
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study.
Lancet Oncol. 2020 Apr;21(4):551-560. doi: 10.1016/S1470-2045(20)30060-7. Epub 2020 Mar 11.
6
CLAG-M chemotherapy followed by umbilical cord blood stem cell transplantation for primary refractory acute myeloid leukaemia in a child: A case report.
World J Clin Cases. 2020 Nov 26;8(22):5603-5610. doi: 10.12998/wjcc.v8.i22.5603.
7
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial.
Lancet Oncol. 2017 Oct;18(10):1317-1326. doi: 10.1016/S1470-2045(17)30576-4. Epub 2017 Aug 24.
8
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial.
Lancet Haematol. 2021 Aug;8(8):e552-e561. doi: 10.1016/S2352-3026(21)00192-7.
9
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study.
Lancet Oncol. 2015 Sep;16(9):1099-1110. doi: 10.1016/S1470-2045(15)00038-8. Epub 2015 Aug 19.
10
Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.
Br J Haematol. 1993 Jul;84(3):416-22. doi: 10.1111/j.1365-2141.1993.tb03095.x.
本文引用的文献
1
OBSERVATIONS ON THE BLOOD IODINE. I. THE BLOOD IODINE IN HEALTH, IN THYROID AND CARDIORENAL DISEASE, AND IN LEUKEMIA.
J Clin Invest. 1940 May;19(3):515-24. doi: 10.1172/JCI101155.
Zotero 插件